Tag: Supriya Lifescience expands global footprint with Esketamine Hydrochloride approval & Atorvastatin patent filing

•    Supriya Lifescience becomes the first Indian company to receive nod for Esketamine Hydrochloride from Brazil’s health authority ANVISA. •    Supriya Lifescience have developed groundbreaking technique for low-cost manufacturing of Atorvastatin, which is worldwide used for a key treatment for controlling cholesterol and preventing cardiovascular disease. Mumbai : Supriya Lifescience Ltd., a global pharmaceutical industry leader, achieved two […]